| Dr Anne Elizabeth Codere Kelly, MD | |
|
10101 Ridgegate Pkwy, Lone Tree, CO 80124-5522 | |
| (303) 338-4545 | |
| Not Available |
| Full Name | Dr Anne Elizabeth Codere Kelly |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 10 Years |
| Location | 10101 Ridgegate Pkwy, Lone Tree, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093134942 | NPI | - | NPPES |
| 029055 | Other | CO | KAISER COMMERCIAL NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 036144083 (Illinois) | Secondary |
| 208M00000X | Hospitalist | 036144083 (Illinois) | Secondary |
| 208M00000X | Hospitalist | DR.0063680 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sky Ridge Medical Center | Lone tree, CO | Hospital |
| Hca-healthone Dba Swedish Medical Center | Englewood, CO | Hospital |
| Aurora South Hospital And Medical Center | Aurora, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Colorado Permanente Medical Group Pc | 1254238454 | 1113 |
News Archive
Contrary to other research, a new study found that the total level of antioxidants in people's diets is not related to their risk of developing stroke or dementia.
454 Life Sciences, a Roche Company, announced today that it has entered an exclusive partnership with DNA Electronics for the development of a low-cost, high-throughput DNA sequencing system. As part of the agreement, Roche has signed a non-exclusive license for relevant IP from DNA Electronics' proprietary semiconductor technology portfolio, which enables sensitive detection of nucleotide incorporation during sequencing.
The oral hormone therapy conjugated equine estrogens, which is used by women to relieve menopause symptoms, appears to be associated with increased risk for venous thrombosis (VT, blood clots) and possibly myocardial infarction (heart attack), but not ischemic stroke risk, when compared with the hormone therapy oral estradiol, according to a study published by JAMA Internal Medicine, a JAMA Network publication.
The Queensland Health authorities have issued warnings to residents and tourists in the Emerald region regarding mosquitoes, biting midges (commonly known as sand flies) and black flies in areas affected by flooding. The Council insect control programs are helping with reducing the number of insects, say authorities but people still need to protect themselves to reduce the risk of being bitten in the next few weeks.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
› Verified 2 days ago
| Entity Name | Colorado Permanente Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760599724 PECOS PAC ID: 1254238454 Enrollment ID: O20031216000640 |
News Archive
Contrary to other research, a new study found that the total level of antioxidants in people's diets is not related to their risk of developing stroke or dementia.
454 Life Sciences, a Roche Company, announced today that it has entered an exclusive partnership with DNA Electronics for the development of a low-cost, high-throughput DNA sequencing system. As part of the agreement, Roche has signed a non-exclusive license for relevant IP from DNA Electronics' proprietary semiconductor technology portfolio, which enables sensitive detection of nucleotide incorporation during sequencing.
The oral hormone therapy conjugated equine estrogens, which is used by women to relieve menopause symptoms, appears to be associated with increased risk for venous thrombosis (VT, blood clots) and possibly myocardial infarction (heart attack), but not ischemic stroke risk, when compared with the hormone therapy oral estradiol, according to a study published by JAMA Internal Medicine, a JAMA Network publication.
The Queensland Health authorities have issued warnings to residents and tourists in the Emerald region regarding mosquitoes, biting midges (commonly known as sand flies) and black flies in areas affected by flooding. The Council insect control programs are helping with reducing the number of insects, say authorities but people still need to protect themselves to reduce the risk of being bitten in the next few weeks.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anne Elizabeth Codere Kelly, MD 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: (303) 338-4545 | Dr Anne Elizabeth Codere Kelly, MD 10101 Ridgegate Pkwy, Lone Tree, CO 80124-5522 Ph: (303) 338-4545 |
News Archive
Contrary to other research, a new study found that the total level of antioxidants in people's diets is not related to their risk of developing stroke or dementia.
454 Life Sciences, a Roche Company, announced today that it has entered an exclusive partnership with DNA Electronics for the development of a low-cost, high-throughput DNA sequencing system. As part of the agreement, Roche has signed a non-exclusive license for relevant IP from DNA Electronics' proprietary semiconductor technology portfolio, which enables sensitive detection of nucleotide incorporation during sequencing.
The oral hormone therapy conjugated equine estrogens, which is used by women to relieve menopause symptoms, appears to be associated with increased risk for venous thrombosis (VT, blood clots) and possibly myocardial infarction (heart attack), but not ischemic stroke risk, when compared with the hormone therapy oral estradiol, according to a study published by JAMA Internal Medicine, a JAMA Network publication.
The Queensland Health authorities have issued warnings to residents and tourists in the Emerald region regarding mosquitoes, biting midges (commonly known as sand flies) and black flies in areas affected by flooding. The Council insect control programs are helping with reducing the number of insects, say authorities but people still need to protect themselves to reduce the risk of being bitten in the next few weeks.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
› Verified 2 days ago
Dr. Robert Heineman, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10099 Ridgegate Pkwy Ste 200, Lone Tree, CO 80124 Phone: 720-476-3364 | |
Dr. Kenneth A Gotaas, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 10101 Ridgegate Pkwy, Lone Tree, CO 80124 Phone: 303-338-4545 | |
Andrzej Dankowski, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9615 Aspen Hill Cir, Lone Tree, CO 80124 Phone: 303-960-5486 Fax: 303-792-2447 | |
Dr. Justin Adrian Edward, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 10240 Park Meadows Dr, Lone Tree, CO 80124 Phone: 303-338-4545 | |
Dr. Sophia Nguyen Zwicker, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10101 Ridgegate Pkwy, Lone Tree, CO 80124 Phone: 303-338-4545 |